|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
1/2004
vol. 3 abstract:
The risk of thromboembolic complications due to oral contraception and hormone replacement therapy
Tomasz Stetkiewicz
,
Andrzej Pakalski
,
Grzegorz Stachowiak
,
Ireneusz Połać
,
Sławomir Jędrzejczyk
,
Tomasz Pertyński
(Prz Menopauz 2004; 1: 53–57)
Online publish date: 2004/02/19
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Thromboembolic complications in female users of hormone replacement therapy and oral contraception induced the authors to analyze the influence of sex steroids on some haemostatic elements being important in the potential thrombogenic process within the vascular lumen. Presenting the attainable knowledge on this topic, the aim of this paper was, despite the evident rise in the thrombotic risk during the therapy, not to indispose for hormonal therapy, but to pay attention to the fact that by changing the hormonal dose, route or type, this risk can be minimized, making both therapies as safe as possible for menopausal subjects.
keywords:
thromboembolic disease, oral contraception, HRT, menopause |
 |
